Tobracef

Menu

  • Home
  • About Tobracef
    • In Management of
    • How TOBRACEF Works
    • Clinical Trail Report
  • Physician Information
    • Safety Information
  • Highlights of Tobracef
  • Faq’s
  • Contact Us

Highlights of Tobracef

Home

admin Uncategorized August 28, 2014Ceftazidime, CLINICAL PARTICULARS, Clinical Trail Report, DRUG INTERACTIONS, European GMP approved, First Time in India, Highlights of Tobracef, How TOBRACEF Works, Patented in South Africa, TOBRACEF, Tobramycin 37,987 Comments
Research-Product--by-DSIR-a
  • TOBRACEF ..First Time in India
  • TOBRACEF ..Patented in South Africa
  • TOBRACEF…Unique research product by globally recognized Venus Remedies
  • European GMP approved, World Wide accepted Manufacturing Facilities

Custom Menu

  • In Management of
  • How TOBRACEF Works
  • Clinical Trail Report
  • Safety Information
  • Klebsiella pneumoniae

Tobracef News

Burn Awareness Week 1st – 7th February 2016

Location Map

Click to open larger map

Tags

Ceftazidime CLINICAL PARTICULARS Clinical Trail Report DRUG INTERACTIONS European GMP approved First Time in India Highlights of Tobracef How TOBRACEF Works Patented in South Africa TOBRACEF Tobramycin

Tobracef Faq's

FAQs What is TOBRACEF for ? TOBRACEF is indicated in the treatment of :- Lower respiratory tract infections,  Serious central-nervous-system infections (meningitis) Intra-abdominal infections, including peritonitis, Skin, bone, and skin structure infections, Complicated and recurrent urinary tract infections , Bacterial...

Read more
Copyright © 2023 Tobracef Powered by: Spine Software Systems Pvt.Ltd. (Last updat: 18 May 2016)